Abbott India Limited (NSE:ABBOTINDIA)
India flag India · Delayed Price · Currency is INR
33,210
+270 (0.82%)
Aug 14, 2025, 3:30 PM IST

Abbott India Company Description

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India.

The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management.

It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products.

Abbott India Limited was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002.

The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.

Abbott India Limited
Abbott India logo
Country India
Founded 1910
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 3,659
CEO Kartik Rajendran

Contact Details

Address:
15-16th Floor, Godrej BKC
Mumbai, Maharashtra 400 051
India
Phone 91 22 5046 1000
Website abbott.co.in

Stock Details

Ticker Symbol ABBOTINDIA
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE358A01014
SIC Code 2834

Key Executives

Name Position
Kartik Rajendran MD and Director
Maithilee Mistry Chief Financial Officer
Sangeeta Mukesh Shetty Associate Director - Secretarial, Company Secretary, Nodal Officer and Compliance Officer
Rajan Kalantre Director of Business Human Resources